AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception Lazarus | AI built for Skin Cancer

Enterprise, Skin Cancer, Images, Doctors, Machine Learning, Healthcare, Oncology, Diagnostics, Deep Learning Cambridge, MA, United States

Artificial Intelligence | Machine Learning | Machine Perception

Lazarus | AI built for Skin Cancer

Skin Cancer, Images, Doctors, Machine Learning, Healthcare, Oncology, Diagnostics, Deep Learning

Cambridge, MA, United States

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians. Lazarus CDS helps clinicians make better decisions when it comes to skin cancer screenings. Lazarus CDS was built with input from dermatologists, patients, and clinical support staff to make sure we have the features that you need most. Not only do our neural networks routinely get dermatologist-level classification accuracy, they also clearly explain every single decision, enabling you, the clinician, to feel truly comfortable with every choice you make. With the presence of human error and a lack of dermoscopy, screening for melanoma over telemedicine platforms is famously difficult. Lazarus CDS bridges the gap by giving you a second opinion to make screening lesions over a photo significantly less risky.